Last updated: October 27, 2026

Application No. 18/699,454

STEREOCILIN PROMOTERS AND USES THEREOF

Non-Final OA

Filed

Apr 08, 2024

Priority

Oct 12, 2021 — provisional 63/254,930 +3 more

Examiner

MOLOYE, TITILAYO

Art Unit

1632

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Regeneron Pharmaceuticals Inc.

OA Round

1 (Non-Final)

This examiner grants 62% of cases after interview

— +48.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 557 resolved cases, 2023–2026

Examiner Intelligence

MOLOYE, TITILAYO View full profile →

Grants 62% of resolved cases

Career Allowance Rate

347 granted / 557 resolved

+2.3% vs TC avg

Strong +48% interview lift

Without

With

+48.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 8m

Avg Prosecution

45 currently pending

Career history

607

Total Applications

across all art units

Statute-Specific Performance

§101

4.5%

-35.5% vs TC avg

§103

40.1%

+0.1% vs TC avg

§102

11.2%

-28.8% vs TC avg

§112

32.4%

-7.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 557 resolved cases

Prosecution Timeline

Apr 08, 2024

Application Filed

Sep 16, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/794,265

Patent 12758635

ANTIBODIES AND METHODS FOR TREATING CLAUDIN-ASSOCIATED DISEASES

4y 2m to grant Granted Oct 13, 2026

17/443,786

Patent 12734197

Generation Of Uniform Hepatocytes From Human Embryonic Stem Cells By Inhibiting TGF-BETA and Methods Of Maintaining Hepatic Cultures

5y 1m to grant Granted Sep 15, 2026

17/846,446

Patent 12698339

ANTI-GLYPICAN-1-IMMUNIZING ANTIGEN RECEPTOR

4y 1m to grant Granted Aug 04, 2026

17/044,157

Patent 12680062

FORMATION OF ARRAYS OF PLANAR INTESTINAL CRYPTS POSSESSING A STEM/PROLIFERATIVE CELL COMPARTMENT AND DIFFERENTIATED CELL ZONE

5y 9m to grant Granted Jul 14, 2026

17/956,771

Patent 12667088

ANIMAL MODEL OF BRAIN TUMOR AND MANUFACTURING METHOD OF ANIMAL MODEL

3y 9m to grant Granted Jun 30, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

62%

Grant Probability

99%

With Interview (+48.3%)

3y 8m (~1y 1m remaining)

Median Time to Grant

Low

PTA Risk

Based on 557 resolved cases by this examiner. Grant probability derived from career allowance rate.